Some melasma responds to topical hydroquinone + sunscreen. "Resistant" melasma — typically deeper dermal melasma, common in Latin and Asian skin — doesn't. Resistant cases need a layered approach including oral tranexamic acid, ultra-low-fluence picosecond, and aggressive sun protection.
Why standard treatment fails
Topical hydroquinone treats epidermal melanin. Dermal-component melasma sits below the epidermis, where topicals don't reach effectively. Aggressive lasers backfire — the heat triggers more melanin production.
Resistant melasma often has both epidermal and dermal components. Single-modality approaches address only one layer.
Oral tranexamic acid
Off-label use for melasma (medication originally for bleeding). 250–500 mg twice daily over 3–6 months. Many studies show meaningful improvement in resistant cases. Requires medical supervision and contraindications screening.
Mechanism: inhibits melanocyte plasminogen activation. Works systemically; addresses dermal component.
Ultra-low-fluence picosecond toning
Multiple-pass picosecond at sub-clinical fluence. Doesn't trigger melanocyte activation. 6–10 sessions, 4 weeks apart. Elyzea melasma picosecond: S/300 (~US$86).
Critical: must be ultra-low-fluence. Higher fluences flare melasma significantly.
Strict topical regimen
Hydroquinone 4 % cycling + tretinoin + niacinamide + tranexamic acid topical + tinted mineral SPF 50+ daily.
Topical tranexamic acid (3% concentration) provides additional benefit alongside oral.
Hormonal trigger management
Many melasma cases are estrogen-driven. Switching to non-estrogen contraception, post-pregnancy timing, and managing thyroid levels can be more impactful than any laser.
Discuss with PCP or gynecologist alongside aesthetic treatment.
What to avoid
Aggressive resurfacing, IPL, Q-switched lasers at standard fluences, citrus topical exfoliants. All can flare resistant melasma significantly. Standard melasma guide.
Realistic expectations
Resistant melasma management is a 6-12+ month process. 60-80% improvement realistic; 100% clearance rare. Lifelong management is the expected pattern.
Even apparent clearance can recur with sun exposure or hormonal events.
Trip planning for resistant melasma
Multi-trip strategy over 6-12 months:
- Trip 1: Initial assessment, picosecond session 1, topical regimen start
- Trips 2-6: Picosecond sessions 2-6 spaced 4 weeks apart
- Maintenance trips: annual or as flares occur
Frequently asked questions
Is oral tranexamic acid safe?
Generally safe with medical supervision. Rare side effect: clotting risk in predisposed patients.
What's the difference between epidermal and dermal melasma?
Wood's lamp examination differentiates. Dermal harder to treat.
Can I prevent flares?
Strict sun avoidance + topicals + avoiding heat/hormonal triggers reduces flare frequency.
What about pregnancy melasma?
Often resolves post-pregnancy. Treat post-breastfeeding.
How does this compare to chloasma?
Chloasma is the older term for the same condition.
Will my husband / partner notice?
Severity varies. Many partners are supportive of treatment efforts.
What about new treatments coming?
Continued research in melanocyte-targeted topicals and devices.
Bottom line
Resistant melasma = oral tranexamic + ultra-low-fluence picosecond + strict topical + hormonal management. 60-80% improvement realistic over 6-12 months. Lifelong maintenance pattern. Lima makes ongoing treatment more economically accessible.